Skip to main content

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
Cancel
×
×
Home
  • Home
Article

A decade of biological-psychiatric research in OCD (II): challenge-studies and neuroanatomical substrate

  • A.S. De Leeuw (a1), H.G.M. Westenberg (a1) and J.A. Den Boer (a1)
Summary

In this second part of a review on OCD, challenge-tests are discussed and an overview is given of neuro-imaging studies. Subsequently some hypotheses concerning the pathogenesis of OCD are reviewed. The serotonin (5-HT) agonist metachloro-phenylpiperazine (mCPP) was found to lead to an increase in obsessive-compulsive symptoms. These studies revealed a dissociation between the behavioral and the neuroendocrine responses: OCD-patients showed a blunted hormonal respons compared to controls. Possibly different receptor subtypes are involved. One study is reported with a 5-HT1a agonist as a probe. This study lends no support to an involvement of the 5-HT1a receptor. Tests with noradrenergic probes showed unequivocal results.

Research on the neuroanatomic substrate of OCD is critically reviewed. PET-scan studies point to a possible role of the (orbito-)frontal cortex and the basal ganglia in OCD. Keywords: obsessive-compulsive disorder, OCD, challenge-test, serotonin (5-HT), mCPP, PET-scan.

Copyright
COPYRIGHT: © Scandinavian College of Neuropsychopharmacology 1993
Corresponding author
Academisch Ziekenhuis Utrecht, Afdeling Biologische Psychiatrie, Heidelberglaan 100, 3584 CX Utrecht
References
Hide All
1. De Leeuw, AS, Den Boer, JA, Westenberg, HGM. Een decennium biologisch psychiatrisch onderzoek bij obsessieve-compulsieve stoornis (I): inleiding en behandelingsonderzoeken. Acta Neurop-sychiat 1993; 5: 1–6.
2.Kahn, RS, Wetzler, S. m-Chlorophenylpiperazine as a probe of serotonin function. Biol Psychiat 1991; 30: 1139-66.
3.Zohar, J, Mueller, EA, Insel, TR, Zohar-Kadouch, RC, Murphy, DL. Serotonergic responsivity in obsessive-compulsive disorder: comparisons of patients and healthy controls. Arch gen Psychiat 1987;44:946-51.
4.Hollander, E, DeCaria, CM, Nitescu, A, Gully, R, Suckow, RF, Cooper, TB, Gorman, JM, Klein, DF, Liebowitz, MR. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Arch gen Psychiat 1992;49:21-8.
5.Pigott, TA, Zohar, J, Hill, JL, Bernstein, SE, Grover, GN, Zohar-Kadouch, RC, Murphy, DL. Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpi-perazine in patients with obsessive-compulsive disorder. Biol Psychiat 1991; 29: 418-26.
6.Charney, DS, Goodman, WK, Price, LH, Woods, SW, Rasmussen, SA, Heninger, GR. Serotonin function in obsessive-compulsive disorder. Arch gen Psychiat 1988; 45: 177-85.
7.Zohar, J, Insel, TR, Zohar-Kadouch, RL, Hill, JL, Murphy, DL. Serotonergic responsivity in obsessive-compulsive disorder: effects of chronic clomipramine treatment. Arch gen Psychiat 1988; 45: 167-72.
8.Pigott, TA, Yoney, TH, L'Heureux, F. Serotonergic responsivity to m-CPP in OCD patients during clomipramine and fluoxetine treatment. Biol Psychiat 1990; 27: 41A–179A.
9.McBride, PA, DeMeo, MD, Sweeney, JA, Halper, J, Mann, JJ, Shear, MK. Neuroendocrine and behavioral responses to challenge with the indirect serotonin agonist dl-fenfluramine in adults with obsessive-compulsive disorder. Biol Psychiat 1992; 31: 19–34.
10.Lesch, KP, Höh, A, Disselkamp-Tietze, J, Wiesmann, M, Osterheider, M, Schulte, HM. 5-Hydroxytryptaminela receptor responsivity in obsessive-compulsive disorder. Comparison of patients and controls. Arch gen Psychiat 1991; 48: 540-7.
11.Lesch, KP, Höh, A, Schulte, HM, Osterheider, M, Mueller, T. Long-term fluoxetine treatment decreases 5-HT1a receptor responsivity in obsessive-compulsive disorder. Psychopharmacol 1991b; 105: 415-20.
12.Rasmussen, SA, Goodman, WK, Woods, SW, Heninger, GR, Charney, DS. Effects, of yohimbine in obsessive-compulsive disorder. Psychopharmacol 1987; 93: 303-13.
13.Hollander, E, Decaria, C, Nitescu, A, Cooper, T, Stover, B, Gully, R, Klein, DF, Liebowitz, MR. Noradrenergic function in obsessive-compulsive disorder: behavioral and neuroendocrine responses to Clonidine and comparison to healthy controls. Psychiat Res 1991; 37: 161-77.
14.Behar, D, Rapoport, JL, Berg, CJ, Denckla, MB, Mann, L, Cox, C, Fedio, P, Zahn, T, Wolfman, MG. Computerized tomography and neuropsychological test measures in adolescents with obsessive-compulsive disorder. Am J Psychiat 1984; 141: 363-9.
15.Luxenberg, JS, Swedo, SE, Flament, MF, Friedland, RP, Rapoport, J, Rapoport, SI. Neoroanatomical abnormalities in obsessive-compulsive disorder detected with quantitative X-ray computed tomography. Am J Psychiat 1988; 145: 1089-93.
16.Baxter, LR, Phelps, ME, Mazziota, JC, Guze, BH, Schwartz, JM, Selin, CE. Local cerebral glucose metabolic rates inobsessive-compulsive disorder. A comparison with rates in unipolar depression and normal controls. Arch gen Psychiatry 1987; 44: 211-8.
17.Baxter, LR, Schwartz, JM, Mazziotta, JC, Phelps, ME, Pähl, JJ, Guze, BH, Fairbanks, L. Cerebral glucose metabolic rates in non-depressed patients with obsessive-compulsive disorder. Am J Psychiat 1988; 45: 1560-3.
18.Swedo, SE, Shapiro, MB, Grady, CL, Cheslow, DL, Leonard, HL, Kumar, A, Friedland, R, Rapoport, SI, Rapoport, JL. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch gen Psychiat 1989; 46: 518-23.
19.Martinot, JL, Allilaire, JF, Mazoyer, BM, Hantouche, E, Huret, JD, Legaut-Demare, F, Deslauriers, AG, Hardy, P, Pappata, S, Baron, JC, Syrota, A. Obsessive-compulsive disorder: a clinical, neuropsychological and positron emission tomography study. Acta psychiat scand 1990; 82: 233-42.
20.Zohar, J, Insel, TR, Faith Berman, K, Foa, EB, Hill, JL, Weinberger, DR. Anxiety and cerebral blood flow during behavioral challenge. Dissociation of central from peripheral and subjective measures. Arch gen Psychiat 1989; 46: 505-10.
21.Machlin, SR, Harris, GJ, Pearlson, GD, Hoehn-Saric, R, Jeffrey, P, Camargo. Elevated medial-frontal cerebral flood flow in obsessive-compulsive patients: a SPECT study. Am J Psychiat 1991; 148: 1240-2.
22.Hoehn-Saric, R, Pearlson, GD, Harris, GJ, Machlin, SR, Camargo, EE. Effects of fluoxetine on regional cerebral blood flow in obsessive-compulsive patients. Am J Psychiat 1991; 148: 1243-5.
23.Hollander, E, Schiffman, E, Cohen, B, Rivera-Stein, MA, Rosen, W, Gorman, JM, Fyers, AJ, Papp, L, Liebowitz, MR. Signs of central nervous system dysfunction in obsessive-compulsive disorder. Arch gen Psychiat 1990; 47: 27–32.
24.Laplane, D, Levasseur, M, Pillon, B, Dubois, B, Baulas, M, Mazoyer, B, Tran Dinh, S, Sette, G, Danze, F, Baron, JC. Obsessive-compulsive and other behavioural changes with bilateral basal ganglia lesions. Brain 1989; 112: 699–725.
25.Rapoport, JL, Wise, SP. Obsessive-compulsive disorder: evidence for basal ganglia dysfunction. Psychopharmacol Bull 1988; 24: 380–4.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Acta Neuropsychiatrica
  • ISSN: 0924-2708
  • EISSN: 1601-5215
  • URL: /core/journals/acta-neuropsychiatrica
Please enter your name
Please enter a valid email address
Who would you like to send this to? *

CAPTCHA *

Skip to the audio challenge
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 7 *
Loading metrics...

Abstract views

Total abstract views: 184 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 12th June 2018. This data will be updated every 24 hours.

Cancel
Confirm
×